Graell X, Caminal J M, Masuet C, Arias L, Rubio M, Pujol O, Roca G, Arruga J
Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Barcelona, España.
Arch Soc Esp Oftalmol. 2007 Jun;82(6):343-7. doi: 10.4321/s0365-66912007000600005.
To study the age distribution and survival in patients with uveal melanoma.
A retrospective study was performed on 303 patients diagnosed with uveal melanoma. We analysed the clinical characteristics: age, gender, tumor size and origin, follow-up time, systemic state, survival time and cause of death.
The median age of the patients was 60.09 years. The 2-, 5-, and 10-year survival of patients less than 50 years of age at diagnosis was 91.41%, 81.83% and 61.45% respectively. The 2-, 5- and 10-year survival of patients equal to or older than 50 years was 90.86%, 73.18% and 58.28% respectively. No significant difference was found between these two age groups. When we considered a possible relationship between the sex factor and survival, in patients equal to or older than 50 years of age, we found a higher survival in men than in women (log-rank test; p=0.038).
Uveal melanoma in Spain has a similar age distribution to that of other countries, and it is not an infrequent diagnosis in patients under 40 years of age. Survival rates are also similar to that of other series. We have not found any significant difference between the age of our patients and the survival, although if we analysed the subgroups, we found that the men equal to or over 50 years of age had a better survival than the women of the same age.
研究葡萄膜黑色素瘤患者的年龄分布及生存率。
对303例诊断为葡萄膜黑色素瘤的患者进行回顾性研究。我们分析了临床特征:年龄、性别、肿瘤大小及起源、随访时间、全身状况、生存时间及死亡原因。
患者的中位年龄为60.09岁。诊断时年龄小于50岁患者的2年、5年和10年生存率分别为91.41%、81.83%和61.45%。年龄大于或等于50岁患者的2年、5年和10年生存率分别为90.86%、73.18%和58.28%。这两个年龄组之间未发现显著差异。当我们考虑性别因素与生存率之间的可能关系时,在年龄大于或等于50岁的患者中,我们发现男性的生存率高于女性(对数秩检验;p = 0.038)。
西班牙的葡萄膜黑色素瘤年龄分布与其他国家相似,40岁以下患者的诊断并不少见。生存率也与其他系列相似。我们未发现患者年龄与生存率之间有任何显著差异,尽管如果我们分析亚组,我们发现年龄大于或等于50岁的男性比同年龄女性的生存率更高。